FDA Drug Recalls

Recalls / Class II

Class IID-0325-2025

Product

Pravastatin Sodium Tablets 80mg, 90-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-198-90.

Brand name
Pravastatin Sodium
Generic name
Pravastatin Sodium
Active ingredient
Pravastatin Sodium
Route
Oral
NDCs
68462-195, 68462-196, 68462-197, 68462-198
FDA application
ANDA077987
Affected lot / code info
Lot # 17221771, exp. date Aug-25 17230930, exp. date Apr-26 17230931, exp. date Apr-26 17231252, exp. date May-26 17231274, exp. date May-26 17231855, exp. date Aug-26 17231916, exp. date Aug-26 17231917, exp. date Aug-26 17231945, exp. date Aug-26

Why it was recalled

CGMP Deviations

Recalling firm

Firm
Glenmark Pharmaceuticals Inc., USA
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
750 Corporate Dr, N/A, Mahwah, New Jersey 07430-2009

Distribution

Quantity
N/A
Distribution pattern
U.S. Nationwide

Timeline

Recall initiated
2025-03-13
FDA classified
2025-04-08
Posted by FDA
2025-04-16
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0325-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.